Form 4: Zura Bio Director Acquires Share Options
SEC Form 4 Filing
Director Neil Murray Hamilton Graham of Zura Bio Ltd. reports acquisition of share options.
Summary
- On May 21, 2025, Neil Murray Hamilton Graham, a director of Zura Bio Ltd., acquired 51,000 share options with an exercise price of $1.03.
- The options vest in twelve equal monthly installments over one year from the grant date, with any remaining unvested portion vesting before the next annual shareholder meeting, contingent on continued service.
- Following the transaction, Graham directly owns 51,000 derivative securities.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing, so the sentiment is considered neutral.
Industry Context
This is a standard disclosure related to insider transactions, common for publicly traded companies. It provides transparency regarding the holdings and transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 05/21/2025 | Date of earliest transaction: acquisition of share options. |
| 05/21/2025 | Share option grant date. |
| 05/21/2035 | Share option expiration date. |
| 05/22/2025 | Date of signature for the Form 4 filing. |
Keywords
Zura Bio, Director, Share Options, Form 4, Beneficial Ownership, Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.